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Abstract: Retinal stem cells bear potency of proliferation, self-renewal, and differentiation 
into  many  retinal  cells.  Utilizing  appropriate  sensors  one  can  effectively  detect  the  
self-renewal and aging process abilities. Silencing information regulator (SirT1), a member 
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of the sirtuin family, is a NAD-dependent histone deacetylase and an essential mediator for 
longevity in normal cells by calorie restriction. We firstly investigate the SirT1 mRNA 
expression in retinal stem cells from rats and 19 human eyes of different ages. Results 
revealed that SirT1 expression was significantly decreased in in vivo aged eyes, associated 
with poor self-renewal abilities. Additionally, SirT1 mRNA levels were dose-dependently 
increased in resveratrol- treated retinal stem cells. The expression of SirT1 on oxidative 
stress-induced damage was significantly decreased, negatively correlated with the level of 
intracellular  reactive  oxygen  species  production.  Treatment  with  resveratrol  could 
effectively further reduce oxidative stress induced by H2O2 treatment in retinal stem cells. 
Importantly, the anti-oxidant effects of resveratrol in H2O2-treated retinal stem cells were 
significantly abolished by knockdown of SirT1 expression (sh-SirT1). SirT1 expression 
provides a feasible sensor in assessing self-renewal and aging process in retinal stem cells. 
Resveratrol  can  prevent  reactive  oxygen  species-induced  damages  via  increased  retinal 
SirT1 expression. 
Keywords: retinal stem cells; aging; SirT1; resveratrol 
 
1. Introduction 
The  silent  information  regulator  2  (Sir2),  a  NAD
+-dependent  protein  deacetylase,  promotes 
longevity in yeast and mammalian cells [1]. Cells with an increase in Sir2 activity display a much 
longer lifespan than wild-type cells. Sir2 has an effect on anti-aging, and cells lacking Sir2 have a 
reduced replicative lifespan. This event may be regulated through hypersilencing of the formation of 
extrachromosomal ribosomal DNA circles in the nucleoli; a known cause of senescence in yeast [1]. 
Caloric restriction (CR) has already been reported as the key contributor to longevity in species from 
yeast and nematodes to rodents and monkeys. It is thought that CR slows the metabolic rate, generating 
more  free  NAD  co-factors,  resulting  in  greater  active  Sir2  deacetylase  activity,  and  an  extended 
lifespan [2,3]. Thus, The NAD
+ dependency links Sir2 activity to metabolic changes. Furthermore, Sir2 
and other related members of the sirtuin family are highly conserved from yeast to mammalian cells. 
The SirT1 gene encodes a member of the sirtuin family of proteins, homologs of the Sir2 gene in yeast, 
and contains the catalytic core domain of Sir2 [4,5]. SirT1, which resides in the nucleus, binds and 
deacetylates p53, NF-B, and forkhead transcription factors, as well as histones [6]. SirT1 has many 
biological  functions,  including  transcription  regulation,  cell  differentiation  inhibition,  cell  cycle 
regulation, and anti-apoptosis. In addition, SirT1 is postulated to have capacity of neuroprotection and 
prevents from neurodegeneration and diabetes [7-9]. However, the role of SirT1 being a sensor in  
self-renewal and aging in mammals remains to be further evaluated. 
Retinal  degeneration  such  as  age-related  macular  degeneration  (AMD)  is  the  leading  cause  of 
irreversible blindness in developed countries and accounts for 8.7% of all cases of blindness globally [10]. A 
complex interaction of demographic, genetic and environmental risk factors is thought to exist in the 
etiology  and  pathogenesis  of  AMD.  The  most  established  risk  factors  associated  with  AMD  are 
advanced  age,  cigarette  smoking,  diet  and  race  [11].  Genetic  variations  in  complement  activities Sensors 2010, 10                                       
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(complement factor H, component 2 and factor B) and in mitochondrial-associated protein (age-related 
maculopathy susceptibility 2) lead to excess macular inflammation and retinal oxidative stress involved 
in the development of AMD [12]. Persistent chronic inflammatory and oxidative cell damage gradually 
results in permanent photoreceptor loss and retinal pigment epithelium dysfunction in patients with 
advanced  AMD.  Replacement  of  lost  retinal  cells  by  stem  cell-based  therapy  offers  a  potential 
therapeutic approach to restore visions in advanced AMD patients. Retinal stem cells (RSCs), derived 
from pigmented ciliary margin of the eyes, have been isolated and defined as cells with the capacity of 
self-renewal  and  multilineage  differentiation  [13].  These  cells  bear  multipotency  of  proliferation,  
self-renewal and differentiation into bipolar neurons, Muller glia and photoreceptors. Murine RSCs 
transplanted  into  damaged  or  dystrophic  retina  are  shown  to  differentiate  into  variable  retinal  
neurons [14-16]. RSCs possess the potential to develop the transplantation strategies for retinogenesis 
in retinodegenerative diseases [17,18]. 
The specific aim of this study was to evaluate the effects of SirT1 activation on self-renewal and 
oxidative stress-induced aging of RSCs. SirT1 mRNA expression levels were examined in RSCs from 
rats and human eyes of different ages. Resveratrol (trans-3,5,4'-trihydroxystilbene, RV) is found in the 
skin of red grapes, nuts, pomegranates, and red wine. It is a SirT1-activating compound and possesses 
the ability to scavenge free radicals with promising neuroprotective effects [19-24]. To investigate the 
role of RV in the self-renewal and aging of RSCs, H2O2 was used to mimic the effect of oxidative 
stress in RSCs to explore how RV and SirT1 protect the retinal neurons from oxidative stress. 
2. Results and Discussion 
2.1. Proliferation, Differentiation and Gene Expression of Retinal Stem Cells  
For  in  vitro  culture of  RSCs,  we harvested the freshly isolated RSCs  from  eight SD rats.  The 
harvesting and culture of RSCs was done as previously described [25]. In the serum-free culture, RSCs 
began expansion and formed neurospheres (Figure 1A). The number of neurospheres generated from
 
RSCs after seven days of culture was 17.1 ±  0.6 spheres per 5,000 viable cells. During the process of 
RSC differentiation, the expressions of seven major genes were evaluated at molecular level by RT-PCR 
(Figure 1B). The expression level of nestin was defined as 1, and Table 1 showed the primer pairs used 
in  the  experiment.  Nestin  is  a  maker  of  neural  progenitor  cells.  Hes1  and  Notch1  inhibit  neural 
differentiation  and  maintain progenitor cells,  and both  genes  are also  play a role in  late RSCs  to 
generate glia. Pax6 appears a key controller for the development of eyes and other sensory organs. 
Lack of Pax6 expression could induce expression of ectopic eyes, and produce a wide spectrum of 
ocular defects such as aniridia in humans with heterozygous mutants [26]. Nrl, Brn3b, and GFAP were 
involved  in  the  development  of  the  rod  photoreceptors,  retinal  ganglion  cells,  and  glial  cells, 
respectively. During the process of retinal differentiation, we compare the relative gene expressions at 
day 7 and 14 differentiation with those at baseline. The results showed that the expression of Nestin 
was significantly decreased after 7 and 14 day differentiation (*p < 0.05). Both Hes1 and Notch1 were 
functional  in  Notch  pathway,  which  involved  in  retinal  development.  Only  Notch1  showed 
significantly higher after differentiation (*p < 0.05). The expression of Pax6 revealed higher in RSCs 
after differentiation than fresh RSCs at baseline (*p < 0.05). After 7 and 14 day differentiation, Brn3b, Sensors 2010, 10                                       
 
 
6175 
Nrl and GFAP also showed significantly higher expression (*p < 0.05). In general, the gene expression 
features appeared to be consistent with the process of generating the mature retina from progenitor 
cells [26,27].  
 
Figure 1. Isolation of rat RSCs. (A) In vitro culture of rat RSCs. The ﬂoating neurospheres 
were  derived  from  RSCs  and  cultivated  in  serum-free  medium  with  EGF  and  bFGF.  
Bars: 100 μm. (B) Comparison of the gene expression among fresh RSCs at baseline, RSC 
after 7 and 14 day differentiation in vitro culture. The symbol * indicated a significant 
difference among RSC groups at baseline, day 7 and day 14 differentiation (*p <  0.05;  
**p < 0.01). Data shown here are the means ±  SD of three independent experiments. (C) 
The differentiation ability of RSCs (a-c) RSCs aggregated into spheroid body (a and b, 
blue: DAPI) and expressed nestin protein (d and f; Nestin: green color) and stained with 
musashi1 (e and f; Musashi1: red color). (f) The merged image of nestin and musashi1 
markers  was  co-localized  in  RSCs.  (g–i)  After  14  days  differentiation,  the  retinal 
differentiation  of  RSCs  was  evidenced  by  morphology  and  immunofluorescein  study. 
Fluorescent images were illustrating the differentiated RSCs and positively immunoreacted 
for GFAP (g; GFAP: green color; BrdU: red color), Thy-1 (h; Thy-1: green color; BrdU: 
red color), and rhodopsin (i; rhodopsin: green color; BrdU: red color). Bar: 100 μm. 
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Figure 1C shows the morphology and phenotype of RSC proliferation and differentiation. Initially, 
RSCs  aggregated  into  spheroid  formation  (Figure  1Ca;  merged;  blue:  DAPI),  and  both  neural 
progenitor markers Nestin (green) and Musashi1 (red) were highly detected in these neurospheres by 
using immunofluorescent study (Figure 1Cf; merged). Without expression of mature retinal and neural 
marker,  these  neurospheres  kept  self-renewal  and  proliferation  in  an  undifferentiated  state.  To 
investigate  the  capacity  of  retinal  differentiation,  these  spheroid-like  Nestin  and  
Musashi1-positive  RSCs  were  further  cultured  in  the  differentiated  medium.  Immunophenotypic 
analysis on day 14 showed that differentiated cells expressed GFAP-positive glial cells (Figure 1Cg), 
Thy-1-positive retinal ganglion cells (Figure 1Ch) and rhodopsin-positive photoreceptos (Figure 1Ci). 
Table 1. Sequence of primer pairs used in real-time quantitative RT-PCR. 
Gene  Primer sequence (5′-3′) 
Nestin 
F: GGGCCAGCACTCTTAGCTTTGATA  
R: TGAGCCTTCAGGGTGATCCAG 
Hes1 
F: CCAATTTGCCTTTCTCATCC  
R: GGAAGGTGACACTGCGTTAG 
Notch1 
F: CTCCAACTGTGACACCAACC  
R: GCACCCAGATCACACTCATC 
Pax6 
F: CAGCTTCACCATGGCAAACAAC  
R: AGGTATCATAACTCCGCCCATTCA 
Nrl 
F: ACGACCTGGGCAGTAGTCTCAA  
R: GTGTCGGAAGTCATCCAGTTCAA 
Brn3b 
F: CGATGCGGAGAGCTTGTCTTC  
R: GATGGTGGTGGTGGCTCTTACTCT 
GFAP 
F: ACCAGCTTACGGCCAACAGTG  
R: TGTCTATACGCAGCCAGGTTGTTC 
GAPDH 
F: CCTGCGACTTCAACAGCAACTC  
R: GTTGCTGTAGCCGTATTCATTGTCA 
 
2.2. Detection of SirT1 mRNA and Telomerase Activity in Rat Retinal Stem Cells. 
To  investigate  the  relationship  between  aging  and  SirT1  gene  expression,  the  SirT1  mRNA 
expression fold in RSCs was evaluated in SD rats of different ages (2, 4, 6, 8, and 12 months). The 
expression level of SirT1 in 2-month-old group was defined as 1. We used the t-test for comparing 
each group of different ages. Figure 2A shows that the SirT1 mRNA expression level in the RSCs of 
the  12-month-old  groups  were  significantly  lower  than  those  of  the  2-month-old  (**p  <  0.01)  
and 4-month-old (**p < 0.01) groups, as measured by qRT-PCR. The SirT1 mRNA expression level 
was  also  significantly  decreased  in  the  6-  and  8-  month-old  groups  compared  to  the 2-month-old  
(*p  <  0.05)  and  4-month-old  (*p  <  0.05)  groups.  However,  the  SirT1  mRNA  expression  level  
of 2-month-old RSCs was not significantly different from that of 4-month-old cells (p > 0.05). The 
enzyme telomerase allowed for replacement of DNA known as telomeres, which were otherwise lost 
when a cell divided via mitosis. It was possible that the telomere erosion contributed to the normal 
aging process, and a variety of premature aging syndromes were associated with short telomeres [28,29]. 
Telomere  shortening  was  associated  with  cellular  senescence  and  the  mean  telomere  length  had Sensors 2010, 10                                       
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emerged  as  a  replicative  clock  and  a  biomarker  for  biological  aging  in  vivo.  In  our  experiments, 
telomerase activities in RSCs from different ages (2, 4, 6, 8, 10 and 12 months) of rats were detected 
using a telomerase repeat amplification protocol (TRAP) assay. H1299 cell lysate was designed as a 
positive control, and the negative control was without cell lysate. Telomerase activities were found to 
be almost constant among RSC of 2-, 4-, 6-, 8-, and 10-month-old groups, but slightly decreased  
in the 12-month-old group (Figure 2B). The result revealed that RSCs from the older rats yielded lower 
levels of telomerase.  
Figure 2. Detection of SirT1 mRNA and telomerase activity in rat RSCs.(A) The amount 
of SirT1 mRNA was detected by Q-PCR from RSCs of SD rats of different ages, and.  
*p < 0.05; **p < 0.01 versus 2- and 4-month-old RSC groups. Data shown here are the 
means ± SD of three independent experiments. (B) Telomerase activities were quantified 
using a telomerase repeat amplification protocol (TRAP) assay. RSCs from rats in different 
ages  were  lysed  in  CHAPS  lysis  buffer,  and  equal  protein  quantities  (300  ng)  were 
subjected to TRAP analysis to determine telomerase activity. Negative control: without cell 
lysate; positive control: H1299 cell lysate. 
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2.3. Detection of SirT1 mRNA in Human Retinal Stem Cells. 
 
Next, to study the connection between SirT1 and aging in human RSCs, the expression levels of 
SirT1 mRNA in RSCs isolated from the posterior ciliary margin of human donors with different age 
were examined by Q-PCR. Table 2 lists the characteristics of the patients for RSC analysis.  
Table 2. Characteristics of patients for ocular retinal stem cell analysis. 
Eye No.  Case No.  Age (yrs)  Sex  Eye  Death Cause  SirT1 activity 
1  1  6  Male  Right  Traffic accident  +++++ 
2        Left    +++++ 
3  2  9  Male  Right   Traffic accident  +++++ 
4        Left    +++++ 
5  3  23  Male  Right  Traffic accident  +++ 
6        Left    ++ 
7  4  28  Male  Right  Traffic accident  +++ 
8        Left    +++ 
9  5  33  Male  Right  Traffic accident  +++ 
10        left    ++ 
11  6  41  Male  Right  Traffic accident  +++ 
12        Left    ++ 
13  7  52  Male  Right  Stroke  + 
14  8  61  Male  Right  Lung malignancy  ++ 
15        Left    ++ 
16  9  63  Female  Right  Traffic accident  + 
17        Left    ++ 
18  10  66  Male  Right  Traffic accident  + 
19        Left    + 
20  11  68  Male  Right  Stroke  + 
21        Left    + 
22  12  71  Male  Right  Colon malignancy  + 
23        Left    + 
 
A total of 23 eyes from 12 subjects were included in this study. In juvenile group, four eyes were 
from two subjects younger than 10-years-old. The other 19 eyes from 10 subjects were from adults 
(mean age: 50.60 ±  17.93 years old, nine males and one female). Most donors were deceased due to 
traffic  accidenta,  stroke,  or  cancer.  One  subject  had  only  a  single  donor  eye  due  to  exposure 
keratopathy-induced cornea edema, which would not be a good candidate for corneal transplant. The 
expression level of SirT1 in juvenile group was defined as 1. We used the t-test to comparing juvenile 
and adult groups. Figure 3A showed that the SirT1 mRNA expression level in RSCs from adult group 
(n = 19) was significantly decreased compared to that in RSCs from juvenile group (n = 2, **p < 0.01). 
Interestingly, the qRT-PCR analysis further demonstrated that the SirT1 mRNA expression levels were 
significantly decreased in an age-dependent matter. In the adult group, the results showed that there 
was a negative regression relationship between the age and SirT1 mRNA expression levels in RSCs 
(Figure 3B).  Sensors 2010, 10                                       
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Figure  3.  Detection of SirT1 mRNA in RSC isolated from the posterior ciliary margin of 
human donor. (A) The SirT1 mRNA expression level detected by qPCR in RSCs from adult 
groups (n = 19) was significantly decreased compared to that in RSCs from juvenile group with 
donor age younger than 10 years old (n = 2, **p < 0.01). (B) The regression plot showed that the 
SirT1 level was negatively correlated with age in RSCs. (C) Human samples were divided into 
three  groups  based  on  age.  The  bar  chart  demonstrated  that  the  SirT1  mRNA  level  was 
significantly decreased with age.  (D) Neurospheres formation showed increased in patients 
younger  than  50  years  old  (left  upper)  than  those  older  than  65  years  old  (left  lower).  
Bar: 100 μm. Data shown here are the mean  SD of three experiments.  
 
RSCs from the 19 eyes in the adult group were further divided into three groups based on ages. 
Group 1 had eight eyes with a donor age younger than 50 years old. Group 2 had five eyes with donor 
ages between 50 and 65 years old. The other six eyes with donor ages older than 65 years old were 
categorized in group 3. Next, we defined the level of SirT1 mRNA in group 1 as 1. Figure 3C showed 
that the SirT1 mRNA expression level in group 3 RSCs were significantly lower than group 1 RSCs 
(**p < 0.01), as measured by qRT-PCR. The SirT1 mRNA expression level was also significantly 
decreased in group 2 RSCs compared to group 1 RSCs (*p < 0.05). For self-renewal assay, it was also Sensors 2010, 10                                       
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observed  that  the  number  of  floating  neurospheres  on  day  7  was  significantly  reduced  in  the  
group 3 compared with that in the group 1 (Figure 3D). Neurospheres formation showed obviously 
decreased in group 3 (Figure 3D, left lower) than in group 1 (Figure 3D, left upper). The mean number 
of neurospheres  in  group 1 was  61.3 ±  4.8  spheres  per well, which was significantly higher than  
group 2 of 45.6 ±  5.1 spheres per well (*p < 0.05). The number of neurospheres in group 1 also showed 
significantly higher than group 3 of 16.1 ±  2.1 spheres per well (**p < 0.01). These data indicated that 
both SirT1 expression level and self-proliferation ability were decreased with age. SirT1 could be 
indicated as a sensor of self-renewal of human RSCs as well as of RSCs aging. 
2.4. Expression Activities of SirT1 in RSCs of Different Aged (Month-old) Rats by SirT1 Promotor 
Since SirT1 level was highly associated with age, we set up an aging-indicator system using SirT1 
promoter. pDsRed-SirT1p, where the CMV promoter was replaced by SirT1 promoter, was transfected 
into rat RSCs and observed by fluorescence microscopy. Presence of RFP-positive cells demonstrated 
that the transcriptional mechanism, which drove the expression of SirT1, simultaneously turned on the 
expression of RFP (Figure 4A). An alternative monitor method was to transfect pGL2-SirT1p into RSC 
derived from 2- to 12-month-old rats. Figure 4B showed that the activity of SirT1 promoter in the 
RSCs of the 12-month-old groups were significantly lower than those of the 2- and 4-month-old groups 
(**p < 0.01). The activity of SirT1 promoter was also significantly decreased in the 8-month-old group 
compared to the 2- and 4-month-old groups (*p < 0.05). Luciferase assay revealed that the activity of 
SirT1  promoter  was  repressed  associated  with  age  (Figure  4B),  which  was  consistent  with  the 
expression level of SirT1 mRNA (Figure 2A). Figure 4C showed the mean number of neurospheres  
in 8- and 12-month-old groups was significantly lower than 2- and 4-month-old groups (**p < 0.01). 
The  number  of  neurospheres  in  6-month-old  group  also  showed  significantly  lower  
than 2- and 4-month-old groups (*p < 0.05). Thus, the above data suggested that SirT1 could be a 
sensor of cellular activity state. Sensors 2010, 10                                       
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Figure 4. Expression activity of SirT1 in RSCs of different aged rats was evaluated by Sirt1 
promotor. (A) RSCs from 2-month-old rats were transfected with pDsRed-SirT1p. Left: bright 
light. Middle: RFP. Right: merge. (Bar: 40 μm). (B) pGL2-SirT1p was transfected into rat 
RSCs.  After  harvesting  the  cells,  lysates  were  assayed  for  luciferase  activity.  All  relative 
luciferase activities  were normalized with control Renilla luciferase expression. *p < 0.05;  
**p < 0.01 versus 2- and 4-month-old groups. (C) After 7 days of serum-free medium culture, 
the  number  of  neurospheres  was  counted.  Data  shown  here  are  the  mean  SD  of  three 
experiments. *p < 0.05; **p < 0.01 versus 2- and 4-month-old groups. 
 
2.5. Resveratrol (RV) Increase of Cell Viability in Retinal Stem Cells via the Activation of SirT1 
Recently, RV has been proven as a SirT1 activator. To further clarify our findings and to explore the 
effect of RV on RSCs under oxidative stress, we want to determine the most optimal concentration of 
RV based on the SirT1 expression and cell viability. Firstly, RSCs derived from 12-month-old rat were 
treated with different doses of RV (0, 5, 10, 15, and 20 μM). Using Q-PCR, the SirT1 expression level 
was evaluated, and the results suggested that 15 μM RV was the optimal concentration to stimulate the 
expression of SirT1 mRNA in RSCs (**p < 0.01, Figure 5A). We further investigated the cell viability, 
and the results also showed that the most viable cell number was observed after 15 μM RV treatment Sensors 2010, 10                                       
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for 48 hours (*p < 0.05, Figure 5B). For evaluation the role of SirT1 in RV-treated RSCs, the SirT1 
gene  was  silenced  using  a  small  interfering  RNA  (sh-SirT1)  expressed  from  a  lentiviral  vector. 
Western blots showed SirT1 expression levels in RSCs transduced with lentivirus carrying luciferase 
shRNA (sh-Luc; vector control), and SirT1 shRNA (sh-SirT1) in figure 5C. The growth curve revealed 
that downregulation of SirT1 reduced RV-induced proliferation rate in RSCs (*p < 0.05, Figure 5D). 
 
Figure  5.  Resveratrol (RV) increase cell viability in RSCs via the activation of SirT1.  
(A) RSCs from 12-month-old rats were treated with 0, 5, 10, 15, and 20 μM of RV for 48 hours. 
*p < 0.05: 5 µM RV versus control. **p < 0.01: 10, 15 and 20 µM RV versus control.  
(B) Cell viability for 48 hours were shown in RSCs treated with 0, 5, 10, 15, and 20 μM of 
RV. (*p < 0.05: 15 µM RV versus control). (C) Western blots showed SirT1 expression 
levels  in  RSCs  transduced  with  lentivirus  carrying  luciferase  shRNA  (sh-Luc;  vector 
control), and SirT1 shRNA (sh-SirT1). (D) Cell viability for 48 hours were shown in RSCs 
treated with 0 or 15 μM of RV after knock down by sh-Luc or sh-SirT1 (*p < 0.05: 15 µM 
RV versus control; *p < 0.05: 15 µM RV versus 15 µM RV+ sh-SirT1). Data shown here 
are the mean SD of three experiments.  
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2.6. Resveratrol Protects Against H2O2-induced Oxidative Stress in RSCs via the Activation of SirT1 
In this experiment, H2O2 was used to mimic oxidative stress-induced damage in RSCs. After 2 days 
of treatment with or without 15 µM RV , RSCs were treated with 100 molL
–1 H2O2 or vehicle for 8 
h, followed by the detection of SirT1 mRNA level. We defined the SirT1 mRNA level in control group 
as 1. For evaluation the protective effect of RV against H2O2 -induced oxidative stress and the role of 
SirT1, these RSCs were treated with 0 or 15 μM of RV following knock down by vector sh-Luc or  
sh-SirT1. This experiment was divided into seven groups for detection of the expression of SirT1, cell 
viability and the level of intracellular ROS. H2O2 treatment dramatically decreased the expression of 
SirT1 and cell viability (*p < 0.05, figure 6A, 6B), however, the addition of RV could efficiently 
recover  the  expression  of  SirT1  mRNA  and  the  number  of  viable  cells  in  H2O2-treated  RSCs  
(#p  <  0.05,  figure  6A,  6B).  We  found  that  treatment  of  15  µM  RV  significantly  increased  the 
expression of SirT1 mRNA and cell viability than those treated with H2O2 (#p < 0.05, figure 6A, 6B). 
In  H2O2-treated  RSCs,  the  protective  effect  of  RV  was  significantly  suppressed  by  sh-SirT1.  The 
expression of SirT1 mRNA and the number of viable cells showed significantly decreased in RSCs 
treated with H2O2, 15 µM RV and sh-SirT1 compared to those treated with H2O2, 15 µM RV and  
sh-Luc (p < 0.05, figure 6A, 6B).  
Furthermore, the role of SirT1 in production of intracellular reactive oxygen species (ROS) was also 
examined.  The  amount  of  ROS  was  significantly  increased  in  H2O2-treated  RSCs  (*p  <  0.05,  
Figure 6C). The production of ROS was significantly suppressed by 15 µM RV in H2O2-treated RSCs 
(#p < 0.05, figure 6C). The anti-oxidative stress effect of RV was significantly suppressed by sh-SirT1 
in H2O2-treated RSCs. The level of ROS showed significantly higher in RSCs treated with H2O2, 15 µ M 
RV and sh-SirT1 than those treated with H2O2, 15 µM RV and vector sh-Luc (
p < 0.05, figure 6C). 
These data suggest that RV is a potential agent to rescue oxidative stress-induced damage in treated 
RSC cells. The effect of RV for anti-oxidative stress and decrease ROS production could be via the 
SirT1 pathway. 
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Figure 6. Resveratrol Protects Against H2O2-induced damage in RSCs via the Activation 
of  SirT1.  (A)  Total  RNA  was  extracted,  and  SirT1  mRNA  levels  were  examined  by  
Q-PCR.  After  2  days  of  treatment  with  15µM  of  RV,  rat  RSC  were  treated  
with 100 molL
–1 H2O2 or vehicle for 8 h, followed by detection of SirT1 mRNA level  
(A, fold of control) (B) Cell viability for 48 hours were shown in RSCs treated with 0, 15 μM 
of  RV  after  knock  down  by  sh-Luc  or  sh-SirT1  (C)  Reactive  oxygen  species  (ROS) 
production was detected (C, fold of control). *p < 0.05. #p < 0.05. p < 0.05. Data shown 
here are the mean SD of three experiments. 
 
2.7.  Resveratrol  Promoted  SirT1  Activity  and  Enhanced  the  Self-Renewal  Ability  to  Increase  the 
Numbers of Neurospheres in Aged-Retinal Stem Cell 
 
To  directly  monitor  that  whether  RV  regulated  the  SirT1  promoter  activity  in  RSCs,  cells  
from  2-  and  12-month-old  rats  were  transfected  with  either  pDsRed-SirT1p  or  pGL2-SirT1p,  and 
cultured  in  serum  free  medium  with  or without RV. RFP-positive cells  were observed in  spheres 
(Figure  7A).  RV  was  found  to  effectively  promote  the  activity  of  SirT1  promoter  (Figure  7B). 
Treatment of RV activated the expression of SirT1 in RSCs from 2- (**p < 0.01) and 12-month-old Sensors 2010, 10                                       
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rats (*p < 0.05). In the group treated with 15 µM RV, RSCs from 2-month-old rats showed higher 
expression of SirT1 (**p < 0.01) as well as in the group without RV treatment (*p < 0.05). RV was 
also  evaluated  the  ability  of  promoting  sphere  formation.  The  results  showed  that  RV  effectively 
enhanced  the  sphere  formation  in  RSCs  from  12-month-old  rats  (*p  <  0.05),  but  not  in  RSCs  
from 2-month-old rats (p > 0.05, Figure 7C). These data suggested that RV activated the expression of 
SirT1 and significantly enhanced the self-renewal ability of RSCs, especially RSCs from older rats. 
Figure 7. Resveratrol promoted SirT1 activities and enhanced the self-renewal abilities to 
increase  the  number  of  neurospheres  in  retinal  stem  cell.  (A)  RSCs  isolated  
from  2-  and  12-month-old  rats  were  transfected  with  pDsRed-SirT1p.  After  7  days  of 
serum-free culture, RFP-positive cells were detected in spheres. (Bar: 40 μm) (B & C) 
RSCs isolated from 2- and 12-month-old rats were transfected with pGL2-SirT1p. After 7 days 
of serum-free culture with or without RV, cell lysates were assayed for luciferase activity 
(B) relative to 2-month-old rat RSC without RV treatment) and the number of neurospheres 
was counted; (C). *p < 0.05; **p < 0.01. Data shown here are the means ± SD of three 
independent experiments. 
 
2.8. Discussion 
SirT1, a NAD+ dependent histone deacetylase, regulates lifespan and has an effect on aging. Some 
studies have shown the relationship between the aging change, apoptosis, and inducing oxidative stress 
by  inhibition  of  SirT1.  In  this  study,  we  firstly  showed  the  RSCs  and  gene  expression  after 
differentiation  (Figure  1).  In  aging  RSCs,  the  data  showed  that  SirT1  expression  was  limited Sensors 2010, 10                                       
 
 
6186 
(Figure 2).  In  human  RSCs,  the  relative  expression  levels  of  SirT1  mRNA  and  the  formation  of 
neurospheres  in  RSCs  from  group  3  donors  older  than  65  were  significantly  lower  than  those  in 
younger groups (Figure 3). In rats, RSCs from 12-month-old rat also showed lower activities of SirT1 
promoter as well as the decreased number of neurosphere formation (Figure 4). To further clarify our 
findings and explore the underlying mechanism, H2O2 was used to mimic the damage of oxidative 
stress in RSCs. These cells were treated with different doses (5, 10, 15, and 20 μM) of resveratrol 
(RV).  Treatment  with  RV  promoted  the  cell  proliferation,  and  the  effect  showed  decreased  after 
inhibition of SirT1 pathway (Figure 5). With H2O2 treatment, the addition of RV could efficiently 
recover the SirT1 mRNA expression levels and cell viabilities. This effect of RV was significantly 
suppressed in the H2O2-treated RSCs by sh-SirT1 (Figures 6A, 6B). The results showed that ROS 
production was significantly increased in sh-SirT1-treated RSCs compared to a vector control group 
under the same oxidative conditions (Figure 6C). The knockdown of SirT1 by sh-SirT1 significantly 
reversed the anti-oxidative-stress effect of RV in H2O2-treated RSCs (Figures 6B and 6C). This effect 
of RV was demonstrated significant in RSCs from older rats (Figure 7). To the best of our knowledge, 
this is the first study to report that SirT1 may be involved in the abilities of self-renewal and aging in 
RSCs, and that it may regulate the cell damage in oxidative stress-treated RSCs. 
Telomere dysfunction and ROS damage are implicated in age-related decline of stem cells [30]. 
SirT1 may have a role in telomere maintenance during stem cell aging because of its essential role in 
gene  silencing  [31].  SirT1  gene-deleted  mice  display  retarded  growth  rate,  reduced  survival  to 
adulthood, and significantly slower rate of bone mineralization compared to wild type mice [32], all of 
which can be potentially explained by accelerated stem cell aging and attrition. Moreover, SirT1 could 
be  involved  in  stem  cell  aging  by  suppression  of  age-related  ROS  generation  [30,33,34].  
Up-regulation  of  mitochondrial  SirT1/PGC-1α  will  results  in  ROS  generation  decrease  by  forcing 
mitochondrial reprogramming to generate ATP by β-oxidation of fatty acids instead of carbohydrate 
catabolism [31,33-35]. Han et al. demonstrated that ROS-induced cell apoptosis was regulated via 
SirT1 in embryonic stem cells by deacetylation of p53 [34]. Much more apoptotic cells were observed 
in the SirT1 gene-deleted cells than in wildtype cells when embryonic stem cells were treated with 
H2O2  [34].  They  further  found  that  SirT1  cause  p53  localization  to  mitochondria  for  regulating  
self-renewal and limiting ROS toxicity in embryonic stem cells. Recent studies also showed that SirT1 
plays a role in redox status of hematopoietic stem cells and neural progenitor cells [36,37]. SirT1 might 
influence  mitochondrial  function  and  redox  status  with  hematopoietic  stem  cells  aging  via  its 
regulation of PGC-1α together [36,38]. Therefore, SirT1 was involved in the metabolism of these stem 
cells by maintaining proper ROS levels, limiting ROS accumulation and promoting longer stem cell 
life. The linkage of redox status to SirT1 in RSC aging needs to be further elucidated.  
RV is a compound found largely in the skins of red grapes, nuts, pomegranates, and red wine.  
It possesses the ability to scavenge oxidatively generated free radicals, and prevents tumor progression 
by blocking NF-κB expression [17-21]. RV also has promising effects of neuroprotection, slowing 
aging and delaying the onset of chronic diseases [19,22-24]. In retina, the involvement of SirT1 in 
DNA repair and in maintaining energy homeostasis indicates the anti-apoptotic, neuroprotective effect 
of SirT1 expression [39]. RV, an activator of the SirT1 gene, possesses the potential as a scavenger for 
oxidative-stress-induced free radicals and toxicities. In human retinal pigment epithelium cells, RV Sensors 2010, 10                                       
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was evident of neuroprotective effects associated with reduction of oxidative damage on phagocytic 
functions  [40].  In  addition,  the  anti-oxidative  damage  effect  of  RV  could  prevent  cellular  and 
molecular ocular inflammatory response by redox-sensitive NF-κB activation [41]. Furthermore, these 
anti-oxidative  and  anti-senescence  effects  of  RV  showed  clinically  improvement  in  human  visual 
functions [42]. This improvement was associated with the reversal of retinal lipofusin, a waste of retina 
metabolite [42]. This ability of self-renewal was still not clear whether RV acts directly or indirectly in 
RSCs through SirT1. In the present study, the data showed that RV not only activated SirT1 expression 
levels  in  H2O2-treated  RSCs,  but  also  resulted  in  recovery  from  oxidative  
stress-induced damage. Moreover, ROS played a critical role in limiting the lifespan of organisms, as 
well as initiating the process of cellular senescence [43]. Increasing levels of ROS were also shown to 
restrict the lifespan of retinal stem cells. Importantly, with RV treatment, knockdown of SirT1 in RSCs 
increased the ROS production and further enhanced the oxidative stress-induced cell damage (Figure 6). 
Indeed, RSCs lead to impairment of self-renewal functions by inactivation of SirT1. SirT1 expression 
provided a feasible sensor in assessing self-renewal and aging process in RSCs.  
The  present  results  suggest  that  RV  is  a  potential  candidate  for  preventing  the  oxidative  
stress-induced cell damage in RSCs. These data also show that RV can prevent ROS-induced aging 
and cell damage via increased retinal SirT1 expression. RV appears to be a potential anti-oxidant that 
may prevent or slow down the production of ROS. The mechanism of RV-mediated SirT1 activation in 
aging  and  self-renewal  RSCs  needs  further  study.  Its  potential  utility  in  protection  against  retinal 
dysfunction should be further determined. 
3. Experimental Section 
3.1. Isolation of Retinal Stem Cells 
 
All animals used were treated in accordance with Animal Care and Use Committee guidelines at 
Taipei  Veterans  General  Hospital.  Eight  Sprague-Dawley  rats  of  each  different  ages  (2,  4,  6,  8,  
and 12 months) were examined and anesthetized with intraperitoneal Phenobarbital. Human eyes were 
from 19 donors as list in Table 2. The harvesting and culture of RSCs was done as our previously 
described [25]. Briefly, the anterior eye segment was removed under a dissecting microscope and the 
neural  retinal  tissue  was  separated  from  the  pigmented  epithelial  layer.  The  neural  retinal  tissue 
incubated for 10 min at 37 ° C in Hanks’ balanced salt solution containing 0.05% trypsin and then 
mechanically dissociated with Pasteur pipettes in a DMEM/F-12 medium (Gibco) at a ratio of 1:1. 
These dissociated cells were then centrifuged at 150 g for 5 min. Afterwards, the enzyme solution was 
removed, and viable cells were counted by trypan blue exclusion and plated as 5,000 cells/200 µL per 
well
 in 96-well plates (Corning, Acton, MA, USA) replaced with serum-free culture media composed 
of  DMEM/F-12  medium  (Gibcol)  with  insulin  (25  µg/mL),  transferrin  (100  µg/mL), progesterone  
(20 nM), putrescine (60 µM), sodium selenite (30 nM), and human recombinant EGF
 20 ng/mL and 
bFGF 20 ng/mL (R&D Systems, Minneapolis, MN, USA).  
The  number  of  primary  spheres  generated  in  each  well  was  assessed 7 days  after plating. The 
primary suspended spheres were mechanically dissociated into single cells by trituration, and an aliquot 
was counted to determine the total number of cells. For secondary cultures, 500 cells/200 µL per well Sensors 2010, 10                                       
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were plated in each well in 96-well plates using the same culture conditions. The number of secondary 
spheres  in  each  well  in  each  culture  condition  was  scored  7  days  after  plating.  In  this  state,  we 
investigate the self-renewal abilities of RSCs. 
The primary and secondary
 isolated spheres were plated on poly-L-ornithine-coated (15 µg/mL)
 glass 
coverslips in individual wells of 24-well plates (1.0 mL/well)
 in DMEM/F-12 medium containing 2% fetal 
calf serum (FCS; Gibcol) and withdrawing EGF and bFGF. Coverslips were
 processed 8 days later and 
fixed with 4% paraformaldehyde for 20 minutes for the observation of differentiation. 
 
3.2 Quantitative Real-time RT-PCR 
 
PCR reactions were performed on the ABI PRISM
® 7900HT Sequence Detection System and the 
ABI Prism 5700 SDS (Applied Biosystems). The amplification mixtures (50 μL) contained template 
DNA 1 μL, 2 X SYBR Green I Master Mix 25 μL, 0.4 μL of each primer (final concentration 200 nM), 
and  DD  water  to  volume.  Copy  number  changes  per  haploid  genome  were  calculated  using  the  
formula 2
(Nt–Nline)–(Tt–Tline), where Nt is the threshold cycle number observed for an experimental primer 
in the normal DNA sample, Nline is the threshold cycle number observed for a Line-1 primer in the 
normal DNA sample, Tt is the average threshold cycle number observed for the experimental primer in 
the test DNA sample, and Tline is the average threshold cycle number observed for a Line-1 primer in 
the  test  DNA  sample.  The  conditions  for  amplification  were  as  follows:  one  cycle  of  94  ° C  
for 2 minutes, followed by 50 cycles of 94 ° C for 20 seconds, 57 ° C for 20 seconds, and 70 ° C  
for 20 seconds. Reactions for each primer set were performed in triplicate, and the threshold cycle 
numbers were averaged. 
3.3. TRAP Assay 
Telomerase activity was measured with the modified telomere repeat amplification protocol (TRAP) 
assay  [31].  Pelleted  cells  were  lysed  with  100  μL  of  1X  CHAPS  lysis  buffer  (10  mM  Tris-HCl  
(pH 7.5), 1 mM EGTA, 0.5% CHAPS, 10% [v/v] glycerol, 5 mM β-mercaptoethanol, and 0.1 mM 
phenylmethylsulfonyl fluoride), incubated on ice for 30 min and centrifuged (13,000g, 4 °C , 30 minutes). 
Supernatant extracts were quantified for protein with a BSA Protein Assay Kit (Pierce, IL). TRAP 
assay was performed as previously described [44] with only minor modifications, with a set of primers 
(TS, 5’-AATCCGTCGAGCAGAGTT-3’; ACX, 5’-GCGCGGCTTACCCTTACCCTTACCCTAACC-3’; 
NT,  5’-ATCGCTTCTCGGCC  TTTT-3’),  and  an  internal  standard,  TSNT  (5’-AATCCGTCG 
AGCAGAGTTAAAAGGCCG  AGAAGCGAT-3’)  [45].  Reaction  mixtures  were  incubated  
(25 °C , 30 min) for telomerase-mediated extension and the samples were heated to 85 °C  (10 minutes). 
Taq polymerase was added and each sample was amplified for 30 cycles of polymerase chain reaction 
(PCR) amplification (94 °C  for 30 s, 59 °C  for 30 s, and 72 °C  for 90 s) in a DNA thermal cycler 
(GeneAmp PCR System 2400, PerkinElmer Co., Norwalk, CT, USA). TRAP products were resolved 
by 12.5% (w/v) non-denaturing polyacrylamide gel electrophoresis (PAGE) and visualized by staining 
with ethidium bromide. Relative telomerase activities were quantified by comparing signal intensities 
among lane and with the positive control (extract of H1299 cells) as 100%. Sensors 2010, 10                                       
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3.4. The Cloning of SirT1 Promotor, Transfection, and Dual-Luciferase Assay 
For analysis of the SirT1 promoter, a 2.8 kb fragment was PCR-amplified using mouse genomic 
DNA as a template, and subcloned into pDsRed2 (CMV promoter was replaced by SirT1 promoter) 
and  pGL2.  The  Lipofectamine  2000  system  (Life  Technologies,  Grand  Island,  NY)  was  used  for 
transfection of DNA into RSC cells. Brieﬂy, 10
6 cells/well were seeded onto 6-well plates 24 h before 
transfection. DNA solution (250 μl of OPTI-MEM containing 9 μg of pGL2-SirT1p reporter construct 
and 30 ng of pRL-tk Renilla normalizing luciferase vector) and reagent solution (5 μl of LF2000  
and 250 μl of OPTI-MEM) were separately pre-incubated at 25 ° C for 5 minutes. The transfections 
were then followed according to the manufacturer’s instructions. After 48 h of incubation, the cell 
lysates  were  prepared  using  the  dualluciferase  reporter  assay  system  (Promega).  Both  ﬁreﬂy  and 
Renilla  luciferase  activities  were  monitored  by  illuminator  (TD20/20;  Turner  Designs,  
Sunnyvale, CA). 
3.5. Knockdown of SirT1 
The pLVRNAi vector was purchased from Biosettia Inc. (Biosettia, San Diego, CA, USA). The 
method of cloning the double-stranded shRNA sequence is described in the manufacturer’s protocol. 
The oligonucleotide 5’- AAAAGCAGATTAGTAGGCGGCTTGATTGGATCCAATCAAGCCGCCT 
ACTAATCTGC-3’ targeting human SirT1 (NM_012238, nt 1946-1966) were synthesized and cloned 
into pLVRNAi to generate Letiviral expression vector, pLVRNAi/sh-SirT1/1946. The lentiviral vector 
carryed luciferase shRNA is the vector control (sh-Luc; vector control). One day before transfection, 
plate 293FT cells (Invitrogen) at 5  10
6cells per 10 cm plate. Do transfection with Lipofectamine 2000 
reagent  (Invitrogen).  Replace  the  medium  with  5  mL  of  Opti-MEM  I  without  serum.  Prepare  
DNA-Lipofectamine  2000  complex  with  2  μg  of  pVSVg,  4  μg  of  pCMV-ΔR8.91  and  10  μg  of 
pLVRNAi/sh-SirT1/1946 in 3 mL of Opti-MEM I and add the complex to the plate. On the next day, 
replace  the  medium  containing  the  complex  with  complete  culture  medium  containing  serum  and 
antibiotics. Harvest the medium containing virus particles after 72 hour posttransfection. Spin down 
the  medium  to  remove  cell  debris  and  save  the  supernatant.  To  determine  the  lentiviral  titer,  
prepare 10-fold serial dilutions of viral stocks in complete culture medium ranging 1 to 10
6. Remove 
culture media from the 293 FT cells and add 1 mL of the dilutions directly to the cells. If desired, add 
polybrene to each well to a final concentration of 8 μg/mL, and incubate at 37 ° C overnight. The 
following day, replace the media containing virus with fresh complete culture media. After 3–4 days of 
transduction, observe GFP expression under fluorescent microscope and count GFP positive cells and 
estimate the titer. Infections were carried out in the presence of 8 μg/mL of polybrene and 10 mM 
HEPES. Virus-containing supernatant was removed after 24 hours and replaced with complete culture 
media. After 3 to 5 days, the transduced cells were analysed and isolated by flow cytometry which was 
carried out using FACScalibur and Cellquest software. 
3.6. Immunoblot Analysis and Immunofluorescence Assay 
RSCs were fixed, washed once in cold PBS, scraped, lysed with extraction buffer, and centrifuged 
at 10,000 rpm (9,730 g) for 10 minutes to remove insoluble material. Protein concentrations were Sensors 2010, 10                                       
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determined using a protein assay kit (Bio-Rad, Hercules, CA, USA). Cell extracts in sample buffer 
were  placed  in  boiling  water  for  5  minutes  and  then  separated  by  10%  SDS-PAGE  gel.  After 
electrophoresis, the gel was transferred onto a PVDF membrane for immunoblotting. The membrane 
was blocked by incubation in non-fat milk at room temperature for 2 hours and incubated with SirT1 
antibody (1:1000; Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 2 hours at room temperature, 
washed five times with tris-buffered saline tween-20 (TBST), and incubated at room temperature with 
horseradish peroxidase-conjugated secondary antibody for 2 hours. The membrane was washed six 
times with TBST, and specific bands were made visible by chemiluminescence (ECL, Santa Cruz). For 
immunofluorescence study
 with GFAP, Thy-1, and opsin, the differentiated cells immunostained with 
monoclonal antibodies against GFAP (astoglial marker; 1:500; DAKO), Thy-1 (retinal ganglion cell 
marker;1:500; Chemicon), and rhodopsin (photoreceptor marker; 1:500; Chemicon) were diluted in 
PBS/3% Triton
 X-100/10% normal goat serum (NGS) and individually incubated with
 the coverslips 
for 2 hours at 37 ° C. Coverslips were washed three times
 (10 minutes each) in PBS and incubated in 
appropriate  secondary
  antibodies  (1:200;  Sigma,  St  Louis,  MO,  USA)  for  30  minutes  at  37  ° C.
 
Coverslips were rinsed three times in PBS and one time in distilled
 water and mounted on glass slides 
with Fluoesave (Calbiochem,
 La Jolla, CA, USA). The number
 of GFAP-, Thy-1 and opsin-positive 
cells were assessed in 10 non-overlapping
 fields for each sphere. The total number of cells in each field
 
was  determined  by  counterstaining  cell  nuclei  with  4,6-diamidine-2-phenylindole
  dihydrochloride 
(DAPI; 1 mg/mL). 
3.7. H2O2 Treatment 
Cultured RSCs were washed with PBS twice and treated with 100 μM H2O2 in the culture medium. 
After  8  hours,  the  medium  was  removed,  and  the  cells  were  collected  for  the  subsequent  
RNA extraction. 
3.8. Measurement of Intracellular ROS Production 
The measurement of intracellular ROS production by the probe 2',7'-dichlorofluorescein diacetate 
(DCFH-DA; Molecular Probes, Eugene, OR, USA) was mentioned previously [46]. In brief, cells were 
incubated with 5 µmol· L-1 DCFH-DA in culture medium for 30 minutes at 37 C, DCFH-DA was 
metabolized  by  non-specific  esterases  to  the  non-fluorescence  product,  2',7'-dichlorofluoresceine, 
which was oxidized to the fluorescent product, DCF, by ROS. Then the cells were washed twice in 
PBS, trypsinized, resuspended in PBS and measured for their ROS content by flow cytometric analysis.  
3.9. Statistical Analysis 
The  results  are  expressed  as  means  ±   SD.  Statistical  analyses  were  performed  using  t-test  for 
comparing 2 groups, and one-way or two-way ANOVA, followed by Tukey’s test were used to detect 
the difference among 3 or more groups. A P-value is less than 0.05 considered statistically significant. Sensors 2010, 10                                       
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4. Conclusions  
In conclusion, the level of SirT1 could efficiently monitor self-renewal and aging process in RSCs. 
RV could prevent that ROS-induced damage via increased retinal SirT1 expression.  
 
Acknowledgments 
 
This  study  was  supported  by  the  National  Science  Council,  Republic  of  China  
(NSC-96-2314-075-056-MY3,  97-3111-B-075-001-MY3,  98-2314-B-341-001-MY3),  Taipei  
Veterans  General  Hospital  (98:  C1-099;  ER3-001),  Shin-Kong  Wu  Ho-Su  Memorial  Hospital  
(SKH-8302-96-DR-22,  8302-97-DR-25),  Yen-Tjing  Ling  Medical  Foundation,  Technology 
Development  Program  for  Academia  (TDPA;  98-EC-17-A-19-S2-0107),  Department  of  Industrial 
Technology, Ministry of Economic Affairs, Taiwan. 
 
References 
 
1.  Kaeberlein,  M.;  McVey,  M.;  Guarente,  L.  The  SIR2/3/4  complex  and  SIR2  alone  promote 
longevity  in  Saccharomyces  cerevisiae  by  two  different  mechanisms.  Genes  Dev.  1999,  13,  
2570-2580. 
2.  Imai, S.; Armstrong, C.M.; Kaeberlein, M.; Guarente, L. Transcriptional silencing and longevity 
protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000, 403, 795-800. 
3.  Lin, S.J.; Defossez, P.A.; Guarente, L. Requirement of NAD and SIR2 for life-span extension by 
calorie restriction in Saccharomyces cerevisiae. Science 2000, 289, 2126-2128. 
4.  Blander, G.; Guarente, L. The Sir2 family of protein deacetylases. Annu Rev. Biochem. 2004, 73, 
417-435. 
5.  Frye,  R.A.  Characterization  of  five  human  cDNAs  with  homology  to  the  yeast  SIR2  gene:  
Sir2-like  proteins  (sirtuins)  metabolize  NAD  and  may  have  protein  ADP-ribosyltransferase 
activity. Biochem. Biophys. Res. Commun. 1999, 260, 273-279. 
6.  Orimo, M.; Minamino, T.; Miyauchi, H.; Tateno, K.; Okada, S.; Moriya, J.; Komuro, I. Protective 
role  of  SIRT1  in  diabetic  vascular  dysfunction.  Arterioscler.  Thromb.  Vasc.  Biol.  2009,  29,  
889-894. 
7.  Trzaska, K.A.; King, C.C.; Li, K.Y. Kuzhikandathil, E.V.; Nowycky, M.C.; Ye, J.H.; Rameshwar, P. 
Brain-derived  neurotrophic  factor  facilitates  maturation  of  mesenchymal  stem  cell-derived 
dopamine progenitors to functional neurons. J. Neurochem. 2009, 110, 1058-1069. 
8.  Chaudhary, N.; Pfluger, P.T. Metabolic benefits from Sirt1 and Sirt1 activators. Curr. Opin. Clin. 
Nutr. Metab. Care 2009, 12, 431-437. 
9.  Araki, T.; Sasaki, Y.; Milbrandt, J. Increased nuclear NAD biosynthesis and SIRT1 activation 
prevent axonal degeneration. Science 2004, 305, 1010-1013. 
10.  Resnikoff,  S.;  Pascolini,  D.;  Etya’ale,  D.;  Kocur,  I.;  Pararajasegaram,  R.;  Pokharel,  G.P.;  
Mariotti, S.P. Global data on visual impairment in the year 2002. Bull. World. Health. Organ. 
2004, 82, 844-851. Sensors 2010, 10                                       
 
 
6192 
11.  Coleman,  H.R.;  Chan,  C.C.;  Ferris,  F.L.,  III;  Chew,  E.Y.  Age-related  macular  degeneration. 
Lancet 2008, 372, 1835-1845. 
12.  Ding,  X.;  Patel,  M.;  Chan,  C.C.  Molecular  pathology  of  age-related  macular  degeneration.  
Prog. Retin. Eye Res. 2009, 28, 1-18 
13.  Tropepe, V.; Coles, B.L.; Chiasson, B.J.; Horsford, D.J.; Elia, A.J.; Mclnnes, R.R.; Kooy, D. 
Retinal stem cells in the adult mammalian eye. Science 2000, 287, 2032-2036. 
14.  Nishida, A.; Takahashi, M.; Tanihara, H.; Nakano, I.; Takabashi, J.B.; Mizoguchi, A.; Chizuka, I.; 
Honda,  Y.  Incorporation  and  differentiation  of  hippocampus-derived  neural  stem  cells 
transplanted in injured adult rat retina. Invest Ophthalmol. Vis. Sci. 2000, 41, 4268-4274. 
15.  Warfvinge,  K.;  Kamme,  C.;  Englund,  U.;  Wictorin,  K.  Retinal  integration  of  grafts  of  
brain-derived  precursor  cell  lines  implanted  subretinally  into  adult,  normal  rats.  Exp.  Neurol. 
2001, 169, 1-12. 
16.  Whitely, S.J.O.; Ray, J.; Klassen, H.J.; Young, M.J.; Gage, F.H. Survival and integration of neural 
progenitor cells transplanted to the dystrophic mouse retina. Invest Ophthalmol. Vis. Sci. 1999, 40, 
S598. 
17.  Enzmann, V.; Yolcu, E.; Kaplan, H.J.; Ildstad, S.T. Stem cells as tools in regenerative therapy for 
retinal degeneration. Arch. Ophthalmol. 2009, 127, 563-571. 
18.  Lamba, D.; Karl, M.; Reh, T. Neural regeneration and cell replacement: A view from the eye.  
Cell Stem. Cell 2008, 2, 538-549. 
19.  Penumathsa,  S.V.;  Maulik,  N.  Resveratrol:  A  promising  agent  in  promoting  cardioprotection 
against coronary heart disease. Can. J. Physiol. Pharmacol. 2009, 87, 275-286. 
20.  Kao, C.L.; Tai, L.K.; Chiou, S.H.; Chen, Y.J.; Lee, K.S.; Chou, S.J.; Chang, Y.L.; Chang, C.M.; 
Chen,  S.J.;  Ku,  H.H.;  Li,  H.Y.  Resveratrol  promotes  osteogenic  differentiation  and  protects 
against dexamethasone damage in murine induced pluripotent stem cells. Stem. Cells Dev. 2009,  
(In press). 
21.  Kao, C.L.;  Huang,  P.I.; Tsai, P.H.; Tsai, M.L.; Lo, J.F.; Lee, Y.Y.; Chen, Y.J.; Chen, Y.W.;  
Chiou, S.H. Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells 
derived  from  atypical  teratoid/rhabdoid  tumor.  Int.  J.  Radiat.  Oncol.  Biol.  Phys.  2009,  74,  
219-228. 
22.  Mancuso,  C.;  Bates,  T.E.;  Butterfield,  D.A.;  Calafato,  S.;  Cornelius,  C.;  De  Lorenzo,  A.;  
Dinkova Kostova, A.T.; Calabrese, V. Natural antioxidants in Alzheimer's disease. Expert Opin. 
Investig. Drugs 2007, 16, 1921-1931. 
23.  Barger,  J.L.;  Walford,  R.L.;  Weindruch,  R.  The  retardation  of  aging  by  caloric  restriction:  
Its significance in the transgenic era. Exp. Gerontol. 2003, 38, 1343-1351. 
24.  Baur, J.A.; Sinclair, D.A. Therapeutic potential of resveratrol: The in vivo evidence. Nat. Rev. 
Drug Discov. 2006, 5, 493-506. 
25.  Liu,  I.H.;  Chen,  S.J.;  Ku,  H.H.;  Kao,  C.L.;  Tsai,  F.T.;  Hsu,  W.M.;  Lo,  C.W.;  Kuo,  Y.H.;  
Kuo, C.D.;  Lee, C.H.; Chiou,  S.H. Comparison  of the proliferation and differentiation ability 
between  adult  rat  retinal  stem  cells  and  cerebral  cortex-derived  neural  stem  cells. 
Ophthalmologica 2005, 219, 171-176. Sensors 2010, 10                                       
 
 
6193 
26.  Harada,  T.;  Harada,  C.;  Parada,  L.F.  Molecular  regulation  of  visual  system  development:  
More than meets the eye. Genes Dev. 2007, 21, 367-378. 
27.  James, J.; Das, A.V.; Rahnenfü hrer, J.; Ahmad, I. Cellular and molecular characterization of early 
and  late  retinal  stem  cells/progenitors:  Differential  regulation  of  proliferation  and  context 
dependent role of Notch signaling. J. Neurobio. 2004, 61, 359-376. 
28.  Armanios, M.; Alder, J.K.; Parry, E.M.; Karim, B.; Strong, M.A.; Greider, C.W. Short telomeres 
are sufficient to cause the degenerative defects associated with aging. Am. J. Hum. Genet. 2009, 
85, 823-832. 
29.  Ju, Z.; Rudolph, K.L. Telomeres and telomerase in stem cells during aging and disease. Genome. 
Dyn. 2006, 1, 84-103. 
30.  Sharpless, N.E.; DePinho, R.A. How stem cells age and why this makes us grow old. Nat. Rev. 
Mol. Cell Biol. 2007, 8, 703-713. 
31.  Guarente, L. Diverse and dynamic functions of the SIR silencing complex. Nat. Genet. 1999, 23, 
281-285.  
32.  McBurney,  M.W.;  Yang,  X.;  Jardine,  K.;  Hixon,  M.;  Boekelheide,  K.;  Webb,  J.R.;  
Lansdorp, P.M.; Lemieux, M. The mammalian SIR2alpha protein has a role in embryogenesis and 
gametogenesis. Mol. Cell Biol. 2003, 23, 38-54. 
33.  Guarente, L. Mitochondria―A nexus for aging, calorie restriction, and sirtuins? Cell 2008, 132, 
171–176. 
34.  Han, M.K.; Song, E.K.; Guo, Y.; Ou, X.; Mantel, C.; Broxmeyer, H.E. SIRT1 regulates apoptosis 
and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. 
Cell Stem. Cell 2008, 2, 241-251. 
35.  Guarente, L.; Picard, F. Calorie restriction―The SIR2 connection. Cell 2005, 120, 473-482. 
36.  Narala,  S.R.;  Allsopp,  R.C.; Wells,  T.B.; Zhang, G.; Prasad, P.;  Coussens, M.J.;  Rossi,  D.J.; 
Weissman, I.L.; Vaziri, H. SIRT1 Acts as a Nutrient-sensitive growth suppressor and its loss is 
associated with increased AMPK and telomerase activity. Mol. Biol. Cell 2008, 19, 1210-1219. 
37.  Prozorovski, T.; Schulze-Topphoff, U.; Glumm, R.; Baumgart, J.; Schrö ter, F.; Ninnemann, O.; 
Siegert, E.; Bendix, I.; Brü stle, O.; Nitsch, R.; Zipp, F.; Aktas, O. SirT1 contributes critically to 
the redox-dependent fate of neural progenitors. Nat. Cell Biol. 2008, 10, 385-394. 
38.  Kim, M.; Cooper, D.D.; Hayes, S.F.; Spangrude, G.J. Rhodamine-123 staining in hematopoietic 
stem cells of young mice indicates mitochondrial activation rather than dye efflux. Blood 1998, 
91, 4106-4117. 
39.  Jaliffa,  C.;  Ameqrane,  I.;  Dansault,  A.;  Leemput,  J.;  Vieira,  V.;  Lacassagne,  E.;  Provost,  A.;  
Bigot,  K.;  Masson,  C.;  Menasche,  M.;  Abitbol,  M.  Sirt1  involvement  in  rd10  mouse  retinal 
degeneration. Invest. Ophthalmol. Vis. Sci. 2009, 50, 3562-3572. 
40.  Sheu, S.J.; Bee, Y.S.; Chen, C.H. Resveratrol and large-conductance calcium-activated potassium 
channels in the protection of human retinal pigment epithelial cells. J. Ocul. Pharmacol. Ther. 
2008, 24, 551-555. Sensors 2010, 10                                       
 
 
6194 
41.  Kubota, S.; Kurihara, T.; Mochimaru, H.; Satofuka, S.; Noda, K.; Ozawa, Y.; Oike, Y.; Ishida, S.; 
Tsubota, K. Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by 
inhibiting oxidative damage and nuclear factor-kappaB activation. Invest. Ophthalmol. Vis. Sci. 
2009, 50, 3512-3519. 
42.  Richer, S.; Stiles, W.; Thomas, C. Molecular medicine in ophthalmic care. Optometry 2009, 80, 
695-701. 
43.  Yan, L.J.; Sohal, R.S. Analysis of oxidative modification of proteins. Curr. Protoc. Cell Biol. 
2002, Chapter 7: Unit 7.9. 
44.  Falchetti,  M.L.;  Levi,  A.;  Molinari,  P.;  Verna,  R.;  D'Ambrosio,  E.  Increased  sensitivity  and 
reproducibility of TRAP assay by avoiding direct primers interaction. Nucleic Acids Res. 1998, 26, 
862-863. 
45.  Liao,  C.H.;  Hsiao,  Y.M.;  Hsu,  C.P.;  Lin,  M.Y.;  Wang,  J.C.;  Huang,  Y.L.;  Ko,  J.L. 
Transcriptionally mediated inhibition of telomerase of fungal immunomodulatory protein from 
Ganoderma  tsugae  in  A549  human  lung  adenocarcinoma  cell  line.  Mol.  Carcinog.  2006,  45,  
220-229. 
46.  Kao, C.L.; Tai, L.K.; Chiou, S.H.; Chen, Y.J.; Lee, K.S.; Chou, S.J.; Chang, Y.L.; Chang, C.M.; 
Chen,  S.J.;  Ku,  H.H.;  Li,  H.Y.  Resveratrol  promotes  osteogenic  differentiation  and  protects 
against dexamethasone damage in murine induced pluripotent stem cells. Stem. Cells Dev. 2010,  
(In press). 
© 2010 by the authors; licensee MDPI, Basel, Switzerland. This article is an Open Access article 
distributed  under  the  terms  and  conditions  of  the  Creative  Commons  Attribution  license 
(http://creativecommons.org/licenses/by/3.0/). 